ES2062287T3 - Preparacion farmaceutica. - Google Patents

Preparacion farmaceutica.

Info

Publication number
ES2062287T3
ES2062287T3 ES90125410T ES90125410T ES2062287T3 ES 2062287 T3 ES2062287 T3 ES 2062287T3 ES 90125410 T ES90125410 T ES 90125410T ES 90125410 T ES90125410 T ES 90125410T ES 2062287 T3 ES2062287 T3 ES 2062287T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
acceptable salts
relates
physiologically acceptable
preparation containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90125410T
Other languages
English (en)
Inventor
Rolf Dr Gericke
Manfred Dr Baumgarth
Ingeborg Dr Lues
Rolf Dr Bergmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2062287T3 publication Critical patent/ES2062287T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A UN PREPARADO FARMACEUTICO QUE CONTIENE BISOPROLOL Y/O UNA DE SUS SALES FISIOLOGICAMENTE TOLERABLES Y A UN ACTIVANTE DEL CANAL DE POTASIO.
ES90125410T 1990-02-13 1990-12-24 Preparacion farmaceutica. Expired - Lifetime ES2062287T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4004268A DE4004268A1 (de) 1990-02-13 1990-02-13 Pharmazeutische zubereitung

Publications (1)

Publication Number Publication Date
ES2062287T3 true ES2062287T3 (es) 1994-12-16

Family

ID=6399970

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90125410T Expired - Lifetime ES2062287T3 (es) 1990-02-13 1990-12-24 Preparacion farmaceutica.

Country Status (16)

Country Link
EP (1) EP0442141B1 (es)
JP (1) JPH04234813A (es)
KR (1) KR910015294A (es)
AT (1) ATE102031T1 (es)
AU (1) AU642961B2 (es)
CA (1) CA2036091A1 (es)
DE (2) DE4004268A1 (es)
DK (1) DK0442141T3 (es)
ES (1) ES2062287T3 (es)
HU (1) HU208483B (es)
IE (1) IE64207B1 (es)
IL (1) IL97211A (es)
NO (1) NO910566L (es)
NZ (1) NZ237092A (es)
PT (1) PT96719A (es)
ZA (1) ZA911074B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4209071A1 (de) * 1992-03-20 1993-09-23 Merck Patent Gmbh Pharmazeutische zubereitung
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
IE64207B1 (en) 1995-07-12
EP0442141A1 (de) 1991-08-21
DK0442141T3 (da) 1994-03-28
NO910566L (no) 1991-08-14
HU910463D0 (en) 1991-08-28
ATE102031T1 (de) 1994-03-15
CA2036091A1 (en) 1991-08-14
AU642961B2 (en) 1993-11-04
NO910566D0 (no) 1991-02-12
AU7102991A (en) 1991-08-15
IL97211A0 (en) 1992-08-18
DE4004268A1 (de) 1991-08-14
PT96719A (pt) 1991-10-31
JPH04234813A (ja) 1992-08-24
IL97211A (en) 1995-07-31
DE59004798D1 (de) 1994-04-07
HU208483B (en) 1993-11-29
HUT59593A (en) 1992-06-29
EP0442141B1 (de) 1994-03-02
NZ237092A (en) 1993-01-27
IE910473A1 (en) 1991-08-14
ZA911074B (en) 1991-11-27
KR910015294A (ko) 1991-09-30

Similar Documents

Publication Publication Date Title
FI940072A0 (fi) Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
SE8700498D0 (sv) Novel pharmaceologically active compounds
DK543587A (da) Farmaceutisk praeparat stabiliseret mod oxidation
FI895520A0 (fi) Anti-aterosklerotiska diaryl foereningar.
SE8404065D0 (sv) Novel biologically active compounds
ATE38097T1 (de) Stabilisierte, ein enzymkonjugat enthaltende zusammensetzung.
DK0442141T3 (da) Farmaceutisk præparat
DK374988D0 (da) Tertiaere 2,5-dialkyl-3-phenylpiperidin-derivater med opiat-antagonistisk aktivitet og farmaceutiske kompositioner indeholdende forbindelserne
DE3879985T2 (de) Anticonvulsive agenzien.
FI921876A (fi) Farmaceutisk komposition innehaollande diritromycin
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
ES2094757T3 (es) Un factor megacariocitopoyetico.
DK284588D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
DK0579939T3 (da) Phospholipidderivater
ES2064652T3 (es) Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato.
DK116687D0 (da) Farmaceutisk praeparat indeholdende aenovantroneae
DE3762800D1 (de) Benzhydrylthiomethan-derivate enthaltende therapeutische zusammensetzungen.
DE68907609D1 (de) Arzneimittelzusammensetzung.
PT878195E (pt) Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
DE3686177T2 (de) Gut absorbierende pharmazeutische zusammensetzungen.
DE69434010D1 (de) C7-Taxan-Derivate und diese enthaltende pharmazeutische Zusammenstellungen
MX9203359A (es) Nuevas composiciones farmaceuticas de insulina.
DK77591D0 (da) Blood deliming
DK0779075T3 (da) Anvendelse af 3-alpha-hydroxy-5-alpha-androsta-16-en som lægemidler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 442141

Country of ref document: ES